All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your PsOPsA Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2023-06-14T08:14:27.000Z

Editorial theme | Differential diagnosis and the importance of early treatment

Jun 14, 2023
Share:
Learning objective: After reading this article, learners will be able to cite a new development in psoriasis.

Bookmark this article

During the Psoriasis and Psoriatic Arthritis Hub Steering Committee meeting, key opinion leaders met to discuss differential diagnosis and the importance of early treatment in psoriasis and psoriatic arthritis as part of our editorial theme on delayed diagnosis. This recorded discussion was chaired by Peter van de Kerkhof, and featured Ulrich Mrowietz and Paolo Gisondi.

Differential diagnosis and the importance of early treatment in psoriasis and psoriatic arthritis

In this discussion, van de Kerkhof opens by highlighting some of the factors that feed into early treatment of psoriasis and psoriatic disease, and then the impact of a late diagnosis, focusing on the negative impacts on quality of life (QoL). He goes on to discuss the importance of early diagnosis to mitigate this decline in QoL and for long-term sustainable disease control.

Mrowietz closes the discussion by sharing the spectrum of psoriatic disease (Figure 1), discussing how early treatment can be used to target multiple aspects of psoriatic disease, including its comorbidities.

Figure 1. Psoriatic disease spectrum* 

*Adapted from Mrowietz, et al.1

  1. Mrowietz U, Sümbül M, Gerdes S. Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation. J Eur Acad Dermatol Venereol. Online ahead of print. DOI: 10.1111/jdv.19192

Newsletter

Subscribe to get the best content related to Psoriasis and Psoriatic Arthritis delivered to your inbox